Two Sigma Securities’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,991	Closed	-$1.51M	–	1810
2025 Q2	$1.51M	Buy	+11,991	New	+$1.38M	0.19%	124
2024 Q2	–	Sell	-2,380	Closed	-$328K	–	3420
2024 Q1	$328K	Buy	2,380 +777	+48%	+$106K	﹤0.01%	1889
2023 Q4	$211K	Buy	+1,603	New	+$185K	﹤0.01%	2354
2023 Q3	–	Sell	-4,839	Closed	-$456K	–	3291
2023 Q2	$456K	Buy	4,839 +458	+10%	+$44.8K	0.01%	1497
2023 Q1	$443K	Buy	4,381 +2,244	+105%	+$234K	0.01%	1350
2022 Q4	$255K	Buy	+2,137	New	+$250K	0.01%	1696
2022 Q3	–	Sell	-2,773	Closed	-$270K	–	2918
2022 Q2	$270K	Buy	+2,773	New	+$256K	0.01%	1398
2020 Q4	–	Sell	-4,036	Closed	-$388K	–	1855
2020 Q3	$388K	Buy	+4,036	New	+$467K	0.01%	726
2017 Q3	–	Sell	-7,973	Closed	-$367K	–	1120
2017 Q2	$367K	Buy	+7,973	New	+$387K	0.07%	282
2017 Q1	–	Sell	-5,185	Closed	-$201K	–	1041
2016 Q4	$201K	Buy	5,185 +1,004	+24%	+$45.4K	0.07%	454
2016 Q3	$212K	Buy	+4,181	New	+$208K	0.07%	424